Concepedia

Alan Ranhosky

AR

Statistics

Publications

6

Citations

743

H-Index

6

Active since

1988

Affiliations

Boehringer Ingelheim (United States)(Current)

Boehringer Ingelheim (Brazil)

Alan Ranhosky is an author at Boehringer Ingelheim (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

1988–2006

6

Publications

6

The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group.

Alan Ranhosky, Joan Kempthorne‐Rawson · Circulation · 1990 · 289 citations

, , +17

Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study

Abraham Lieberman, Alan Ranhosky, David C. Korts · Neurology · 1997 · 272 citations

, , +17

Pramipexole in Patients with Early Parkinsonʼs Disease

Jean Hubble, William C. Koller, N.R. Cutler et al. · Clinical Neuropharmacology · 1995 · 145 citations

, , +16

Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.

Paul H. Fischer, James K. V. Willson, C Risueño et al. · PubMed · 1988 · 15 citations

, , +12

A phase II trial of PALA+dipyridamole in patients with advanced soft-tissue sarcoma

Ephraim S. Casper, José Baselga, Tracy Smart et al. · Cancer Chemotherapy and Pharmacology · 1991 · 11 citations

, , +8

1–5 of 6